This article has Open Peer Review reports available.
Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China
- Guolin Li†1, 3Email author,
- Fuxia Xie†1,
- Siyu Yan†1,
- Xiaofei Hu1,
- Bo Jin4,
- Jun Wang1,
- Jinfeng Wu1,
- Dazhong Yin1, 2Email author and
- Qingji Xie3
© Li et al.; licensee BioMed Central Ltd. 2013
Received: 27 June 2012
Accepted: 3 May 2013
Published: 4 May 2013
A full evaluation of health conditions is necessary for the effective implementation of public health interventions. However, terms to address the intermediate state between health and disease are lacking, leading the public to overlook this state and thus increasing the risks of developing disease.
A cross-sectional health survey of 1,473 randomly recruited Chinese Han adults of both sexes living in the central region of China. The criteria for diagnosis of subhealth was defined as the presence of ≥ 1 of the following abnormalities: body mass index ≥ 25 kg/m2 or waist circumference ≥ 102 cm in men and 88 cm in women; systolic pressure 120–139 mmHg and/or diastolic pressure 80–89 mmHg; serum triglyceride level ≥ 150 mg/dL and/or total cholesterol level ≥ 200 mg/dL and/or high-density lipoprotein cholesterol level < 40 mg/dL in men and 50 mg/dL in women; serum glucose level 110–125 mg/dL; estimated glomerular filtration rate 60–89 ml/min/1.73 m2; levels of liver enzymes in liver function tests between 41–59 U/L, or with fatty liver disease but < 33% of affected hepatocytes; levels of oxidative stress biomarkers beyond the reference range of 95%; or problems with both sleep quality and psychological state.
The prevalences of subhealth and disease in the central region of China were 36.6% and 43.1%, respectively. The prevalence of disease increased from 26.3% in participants aged 20–39 years, to 47.6% and 78.9% for participants aged 40–59 years and those aged 60 years or older, respectively. Compared with participants aged 20–39, the prevalences of health and subhealth in participants aged 60 years or older decreased by 86.7% and 60.3%, respectively. The prevalence of subhealth was increased in association with increases in lifestyle risk scores, while the prevalences of both health and disease were reduced.
The prevalences of subhealth and disease are high in central China. Subhealth is associated with high lifestyle risk scores. Both the health care sector and the public should pay more attention to subhealth. Lifestyle modifications and/or psychological interventions are needed to ameliorate these conditions.
A full evaluation of health conditions is necessary for the effective implementation of public health interventions. However, terms to address the intermediate state between health and disease are lacking, leading the public to overlook this state, and thus increasing the risks of developing disease. We therefore coined the term ‘subhealth’ by added the prefix ‘sub’ meaning ‘beneath’ to health, to represent pre-disease condition. This was defined as a state characterized by some disturbances in psychological behaviors or physical characteristics, or in some indices of medical examination, with no typical pathologic features.
Although metabolic syndrome, which is a combination of disturbed fasting glucose, fat accumulation and distribution, blood pressure, and blood lipids, meets some characteristics of subhealth, it mainly represents a collection of risk factors for developing type 2 diabetes mellitus and cardiovascular diseases [1–5]. Moreover, even regardless of various diagnostic criteria for metabolic syndrome have been proposed by different organizations [2, 3, 6–10], the metabolic syndrome as an entity might only be of conceptual value, and cardiovascular risk associated with the syndrome seems to be no greater than sum of its components [11, 12]. A recent longitudinal cohort study in non-diabetic individuals has also illustrated that fasting plasma glucose levels are as good as or potentially better than metabolic syndrome for predicting diabetes . Furthermore, the inclusive and exclusive criteria for metabolic syndrome are imperfect, with little or no accounting for psychological behaviors and physical characteristics, and with the inclusion of some diseases, such as hypertension and diabetes [8, 12, 14]. Thus the importance of metabolic syndrome for estimating public health and general health care may be limited.
Considering that allostasis, or homeostasis, is the basis of all physiological and psychological activities [15, 16], allostatic load or stress, should be a common process behind all-cause diseases, and a potential index of overall health conditions. Allostatic load or stress occurs when allostasis is targeted by stressful stimuli, and the normal psychological and/or physiological states, and even health conditions, are threatened [15, 17]. Metabolic syndrome may represent stress largely related to the stressful stimuli of the “coach potato” lifestyle (high calorie intake and physical inactivity). However, stresses induced by other stimuli would also be expected to influence health. Because stress represents disturbed allostasis, a subsequent energy-consuming recovery process is likely to be recruited by several biological systems, leading to enhanced production of reactive oxygen species and consequent oxidative stress. This suggests that oxidative stress, a potential index of general stress, might be regarded as one component of subhealth. Accumulating data indicate an essential role for oxidative stress in the mechanisms underlying the development and progression of metabolic syndrome [18, 19] and even aging and age-related diseases [20, 21]. To the best of our knowledge, no reports have included oxidative stress in assessments of the general public health state.
By combining general stress, psychological behaviors, physical characteristics and some indices of medical examinations, we sought to establish criteria for the diagnosis of subhealth, and to estimate the potential prevalence of subhealth in the central region of China. Subhealth was evaluated in volunteers by measuring oxidative stress, indicated by plasma levels of thiobarbituric acid-reactive substances (TBARS), and by using questionnaires and physical examinations.
The chemicals 1,1,3,3-tetramethoxypropane and thiobarbituric acid were purchased from Sigma-Aldrich (St. Louis, MO, USA). Other chemicals (analytical grade) were from Sangon Biotech Co. Ltd. (Shanghai, China). Water was produced using a Milli-Q Plus purification system (Millipore, Bedford, MA).
Participants and questionnaire
Basic characteristics of the 1473 Chinese adult participants §
All (N =1473)
Health (N = 299)
Subhealth (N = 539)
Disease (N = 635)
Age, mean (SD), years
40.98 (12.11) **
50.67 (15.14) **††
Gender, male, No%
Blood pressure, mean (SD) ,mmHg
119.45 (11.22) **
130.79 (16.92) **††
72.75 (8.67) **
79.93 (12.43) **††
Blood lipids, mean (SD), mmol/L
4.39 (0.84) **
4.54 (0.84) **†
1.53 (1.00) **
1.96 (1.53) **††
FBG, mean (SD), mmol/L
4.77 (0.53) **
5.36 (1.70) **††
BMI, mean (SD), kg/m2
23.40 (2.82) **
24.80 (3.31) **††
Creatinine, mean (SD), μmol/L
84.63 (15.30) **
88.15 (16.86) **††
eGFR, mean (SD), ml/min per 1.73m2
93.82 (15.29) **
86.69 (18.37) **††
Liver function, mean (SD) U/L
26.21 (19.34) **
31.88 (27.93) **††
22.20 (9.10) **
24.64 (11.24) **††
TBARS, mean (SD), μmol/L
3.71 (1.14) **
3.92 (1.36) **†
Sleep quality, well, No (%)
Healthy diet intake, No (%)
791 (53. 70)
Current tobacco consumption, No (%)
Current alcohol intake, No (%)
Physical activity level, >1h/w, No (%)
LRS, mean (SD)
2.44 (1.26) **
2.24 (1.22) ††
The questionnaire recorded information on demographics (age and gender), lifestyle habits (sleep, diet, smoking history, drinking history and physical activity), detailed medical history, and psychological state. The questionnaire included five possible answers for sleep quality: well, insomnia, dreaminess, restless sleep, and other problems. There were six possible options for psychological state: well, fugue, anxiety, nervousness, agitation, and depression. Subjects whose answers contained at least one ‘well’ for sleep quality or psychological state were not classified as suffering from mental subhealth.
Lifestyle risk score
Lifestyle risk scores §
not too well
Physical activity level
After overnight fasting (12 hours), blood samples (5 mL) from the median cubital vein on the inside of the elbow were collected into vacutainer tubes containing ethylene diamine tetra-acetic acid, according to standard blood collection procedures , and stored at 0–4°C. All analyses were carried out within 8 h of sampling.
Stature, body weight and body mass index (BMI) were detected using an ultrasonic body scale (SK-CK; Sonka Electronic Technologies Co. Ltd., Shenzhen, China). The BMI cut-off point for overweight was 25 kg/m2, as advocated by the World Health Organization (WHO) .
After resting for 30 min, each participant’s blood pressure was measured three times in the sitting position, with the right arm relaxed and well supported by a table, at an angle of 45° from the trunk, using an automatic electronic sphygmomanometer (Ken2-BPMSP-1; Pengcheng Healthcare Products Co. Ltd., Shenzhen, China). According to the suggestion of the American Heart Association , subjects whose mean systolic/diastolic blood pressures were ≥ 140 mmHg/90 mmHg, or who were receiving antihypertensive medication were classified as hypertensive, those with blood pressure of 120–139 mmHg/80–89 mmHg but who had never been told that they had high blood pressure were defined as prehypertensives, and those with blood pressure of 90–119 mmHg/60–79 mmHg were classified as normotensive.
Blood lipids (serum total cholesterol and triglycerides), fasting plasma glucose, renal function (serum creatinine) and liver function (aspartate transaminase [AST], and alanine transaminase [ALT]) were measured using a chromatographic enzymatic method with a Mindray BS-40 automatic analyzer (Mindray Co. Ltd., Shenzhen, China). Serum hepatitis B viral antigens and antibodies were detected using a microplate reader (MR-96; Mindray Co. Ltd.). The diagnosis of fatty liver disease (FLD) was based on ultrasound examination using a Mindray DP-9900 Plus Digital B/W Ultrasound System (Mindray Co. Ltd.).
Serum total cholesterol and serum triglycerides were categorized as normal, borderline high, or high, based on the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report . Fasting blood glucose was classified as normal (< 6.0 mM), pre-diabetic (6.1–6.9 mM), or diabetic (> 7.0 mM), on the basis of the WHO criteria [2, 25].
The estimated glomerular filtration rate (eGFR) was calculated from serum creatinine using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula . Based on eGFR, renal function was categorized according to the related classifications [27, 28]: health (eGFR ≥ 90 ml/min/1.73 m2 and no proteinuria), subhealth (60 ≤ eGFR < 90 ml/min/1.73 m2 and no proteinuria) and disease (eGFR < 60 ml/min/1.73 m2 or with proteinuria).
Hepatic health (all diagnostic indices of liver function, FLD and hepatitis B were normal), subhealth (mild FLD or slightly elevated levels of ALT or AST) and disease (hepatitis, severe FLD, high levels of ALT or AST, or both mild FLD and high levels of ALT or AST) were grouped on the basis of liver function tests, FLD and hepatitis B, and related reference ranges or guidelines [29–31].
A modified thiobarbituric acid method  was used to determine the level of oxidative stress in plasma. Level of oxidative stress was expressed as TBARS determined using an LS-50B spectrofluorometer (Perkin-Elmer Corp., Norwalk, USA).
Criteria for diagnosis of subhealth
Criteria for diagnosis of subhealth and disease §
Blood pressure (mmHg)
Fasting blood glucose (mmol/L)
Blood lipids (mmol/L)
Liver function (U/L)
41-59 and without FLD
41-59 and without FLD
FLD (percentage of affected hepatocytes )
<33% and normal liver function
≥ 33%, or <33% and abnormal liver function
Renal function (ml/min per 1.73m2)
Both have some problems
Results were presented as means ± standard deviation (SD). Statistical analysis of data was performed using predictive analytics software statistics 18.0 (SPSS Inc., Chicago, IL). The reference range of 95% for TBARS was calculated based on the TBARS dataset after removal of the outliers using Grubbs’ test at α = 0.05 . The Kruskal-Wallis test was used for comparisons between groups. A P value < 0.05 was considered statistically significant.
The prevalence of health, subhealth, disease by different factors §
Blood pressure, No (%)
Fasting blood glucose, No (%)
Total cholesterol, No (%)
Triglyceride, No (%)
BMI, No (%)
TBARS, No (%)
Liver function, No (%)
eGFR, No (%)
Mental state, No (%)
With other diseases
To our knowledge, this is the first definition for subhealth that fills the terminology gap between health and disease. This definition is necessary to draw people’s attention to their lifestyles, and to allow them to recover their physical and psychological states of health. If we regard health and disease as green and red traffic lights, respectively, then subhealth is the amber light. The absence of any light will increase the risk of a health-state traffic jam, as indicated by the results of this study. Subhealthy participants had the highest LRS, and only the prevalence of subhealth was positively associated with LRS. It is possible that, in the absence of any term defining the subhealthy condition, people fail to see the amber light and do not appreciate the need to make changes to their lifestyles or other factors.
We have therefore developed systematic diagnostic criteria for subhealth, based on the diagnostic criteria for metabolic syndrome [10, 12, 14], supplemented by measures of oxidative stress to represent general stress, combined sleep and psychological state for mental status, CKD-EPI-based eGFR for renal function, and liver related examinations for hepatic function state. These criteria, including general stress and physical and psychological conditions, provide information about the overall state of health. Moreover, a diagnosis is not difficult to achieve. It is possible to focus on an organ for organ-specific subhealth, or add an index of general stress and an easily-completed questionnaire and medical examination for overall subhealth.
The difference between subhealth and disease lies not only in the levels of the indices used, but more importantly in the means to recovery: generally, the cure of disease requires medication, while the threat to public health posed by subhealth can be eliminated simply by psychological interventions and/or lifestyle modifications. Several studies have suggested that physical activity, healthy diet and other lifestyle modifications can favorably affect components of subhealth [34–36]. However, subhealthy individuals are at high risk of developing disease if not treated in time.
Unhealthy lifestyles are associated with high risks of disease and mortality, while lifestyle improvements are associated with reductions in disease and all-cause mortality. Numerous studies have illustrated that healthy diet, moderate exercise, quitting cigarette smoking, and avoiding heavy drinking are separately associated with lower rates of death from all causes [37–42]. However, there are limited published studies reporting the relationship between combined lifestyle factors and mortality or diseases. By assigning a score of 1 for each poor lifestyle factor (unhealthy diet, sleep problems, smoking, drinking, and < 1 hour of physical activity per week) we calculated a combined LRS ranging from 0–5 for each subject. Based on this score, we demonstrated a positive effect of LRS on the prevalence of subhealth, and a negative effect on health and disease. It is possible that participants with disease, but not those defined as subhealthy, paid more attention to their lifestyles, which might explain why the correlations between mortality or disease and independent lifestyle factors was not always consistent.
In this cross-sectional study, we found approximately 80% of Chinese adults were subhealthy or diseased, based on our diagnostic criteria. This result is much higher than the reported prevalence of metabolic syndrome (23.7%), and even higher than the prevalence of one abnormal characteristic of metabolic syndrome (71.2%) reported in the Third National Health and Nutrition Examination Survey . However, appropriate interventions could theoretically recover health from subhealth (with a prevalence of 36.6%). There is therefore an urgent need for the government, especially the health care sector, to make comprehensive efforts to lower the prevalence of subhealth. The cornerstone of intervention should be to reduce the LRS to zero.
The strengths of this study include the fact that it provides the first definition and criteria for the diagnosis of subhealth, making evaluation of the full state of health conditions feasible, and allowing the implementation of effective interventions. The application of LRS to investigate the combined impact of lifestyle factors on subhealth or disease is superior to assessing the independent impact of lifestyle factors. This cross-sectional study revealed a high prevalence of subhealth in the central region of China, which may serve prompt a major health care initiative aimed at treating subhealth, which has previously been ignored.
This study also had several limitations. Firstly, its sample was limited to Chinese Han adults from urban areas in the central region of China, and the applicability of the results to rural residents, and other nationalities and ethnic groups is unknown. Secondly, although TBARS is the most widely used biomarker of oxidative stress, other in vivo biomarkers exist, such as isoprostanes . Finally, the method of evaluating mental conditions by a combination of sleep quality and psychological factors should not be absolute, but modify along with nationality, race and other characteristics of participants.
This study provides the first definition and criteria for the diagnosis of subhealth, making evaluation of the full state of health conditions feasible, and allowing the implementation of effective interventions. The prevalences of subhealth and disease are high in central China. Subhealth is associated with high lifestyle risk scores. Both the health care sector and the public should pay more attention to subhealth. Lifestyle modifications and/or psychological interventions are needed to ameliorate these conditions.
The authors are very grateful to the International Science Editing for language editing, and would like to thank the participants of the study. This study was supported by National 863 Grants of China, (2008AA02Z411), National Natural Science Funds of China (30800207, 31271257), and Science and Technology Project of Hunan Province. The funding sponsors had no role in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.
- Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016/S0140-6736(05)67402-8.View ArticlePubMedGoogle Scholar
- Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15 (7): 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.View ArticlePubMedGoogle Scholar
- Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, American Heart A, National Heart L, Blood I: Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation. 2004, 109 (3): 433-438. 10.1161/01.CIR.0000111245.75752.C6.View ArticlePubMedGoogle Scholar
- Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the adult treatment panel III and the international diabetes federation in united states american and european populations. Am J Cardiol. 2007, 99 (4): 541-548. 10.1016/j.amjcard.2006.08.045.View ArticlePubMedGoogle Scholar
- Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS: Heart disease and stroke statistics–2013 update: a report from the American heart association. Circulation. 2013, 127 (1): e6-e245. 10.1161/CIR.0b013e31828124ad.View ArticlePubMedGoogle Scholar
- Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006, 23 (5): 469-480. 10.1111/j.1464-5491.2006.01858.x.View ArticlePubMedGoogle Scholar
- Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E: Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002, 28 (5): 364-376.PubMedGoogle Scholar
- Expert Panel on Detection E, Treatment of High Blood Cholesterol in A: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486.View ArticleGoogle Scholar
- Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM: American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003, 9 (3): 237-252.PubMedGoogle Scholar
- Third Report of the National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002, 106 (25): 3143-3421.Google Scholar
- Kahn R: Metabolic syndrome–what is the clinical usefulness?. Lancet. 2008, 371 (9628): 1892-1893. 10.1016/S0140-6736(08)60731-X.View ArticlePubMedGoogle Scholar
- Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D: The metabolic syndrome: time for a critical appraisal: joint statement from the american diabetes association and the european association for the study of diabetes. Diabetes Care. 2005, 28 (9): 2289-2304. 10.2337/diacare.28.9.2289.View ArticlePubMedGoogle Scholar
- Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371 (9628): 1927-1935. 10.1016/S0140-6736(08)60602-9.View ArticlePubMedGoogle Scholar
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.View ArticlePubMedGoogle Scholar
- Li G, He H: Hormesis, allostatic buffering capacity and physiological mechanism of physical activity: a new theoretic framework. Med Hypotheses. 2009, 72 (5): 527-532. 10.1016/j.mehy.2008.12.037.View ArticlePubMedGoogle Scholar
- McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007, 87 (3): 873-904. 10.1152/physrev.00041.2006.View ArticlePubMedGoogle Scholar
- McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med. 1998, 338 (3): 171-179. 10.1056/NEJM199801153380307.View ArticlePubMedGoogle Scholar
- Hampton T: Mitochondrial defects may play role in the metabolic syndrome. JAMA. 2004, 292 (23): 2823-2824. 10.1001/jama.292.23.2823.View ArticlePubMedGoogle Scholar
- Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR: Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 2008, 299 (19): 2287-2293. 10.1001/jama.299.19.2287.View ArticlePubMedPubMed CentralGoogle Scholar
- Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev. 1998, 78 (2): 547-581.PubMedGoogle Scholar
- Yin DZ, Chen KJ: The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp Gerontol. 2005, 40 (6): 455-465. 10.1016/j.exger.2005.03.012.View ArticlePubMedGoogle Scholar
- Turgeon ML: Principles of blood collection. Clinical hematology: theory and procedures. Edited by: Turgeon ML. 2004, Philadelphia: Lippincott Williams & Wilkins, 18-40. 4Google Scholar
- WHO-Expert-Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004, 363 (9403): 157-163.View ArticleGoogle Scholar
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560.View ArticlePubMedGoogle Scholar
- Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the australian diabetes, obesity, and lifestyle study (AusDiab). Circulation. 2007, 116 (2): 151-157. 10.1161/CIRCULATIONAHA.106.685628.View ArticlePubMedGoogle Scholar
- Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326/0003-4819-150-9-200905050-00006.View ArticlePubMedPubMed CentralGoogle Scholar
- National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-266.Google Scholar
- Finney H, Newman DJ, Price CP: Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem. 2000, 37 (Pt 1): 49-59.View ArticlePubMedGoogle Scholar
- Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346 (16): 1221-1231. 10.1056/NEJMra011775.View ArticlePubMedGoogle Scholar
- Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology. 2007, 45 (2): 507-539. 10.1002/hep.21513.View ArticlePubMedGoogle Scholar
- Siest G, Schiele F, Galteau M-M, Panek E, Steinmetz J, Fagnani F, Gueguen R: Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem. 1975, 21 (8): 1077-1087.PubMedGoogle Scholar
- Li G, He H, Yan H, Zhao Q, Yin D: Does carbonyl stress cause increased blood viscosity during storage?. Clin Hemorheol Microcirc. 2010, 44 (2): 145-154.PubMedGoogle Scholar
- Grubbs F: Procedures for detecting outlying observations in samples. Technometrics. 1969, 11 (1): 1-21. 10.1080/00401706.1969.10490657.View ArticleGoogle Scholar
- Bianchi C, Penno G, Romero F, Del Prato S, Miccoli R: Treating the metabolic syndrome. Expert Rev Cardiovasc Ther. 2007, 5 (3): 491-506. 10.1586/14779072.5.3.491.View ArticlePubMedGoogle Scholar
- Rector RS, Warner SO, Liu Y, Hinton PS, Sun GY, Cox RH, Stump CS, Laughlin MH, Dellsperger KC, Thomas TR: Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab. 2007, 293 (2): E500-506. 10.1152/ajpendo.00116.2007.View ArticlePubMedPubMed CentralGoogle Scholar
- Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ: Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006, 100 (5): 1657-1665. 10.1152/japplphysiol.01292.2005.View ArticlePubMedGoogle Scholar
- Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J: Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003, 289 (5): 579-588. 10.1001/jama.289.5.579.View ArticlePubMedGoogle Scholar
- Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB: The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. New Engl J Med. 1993, 328 (8): 538-545. 10.1056/NEJM199302253280804.View ArticlePubMedGoogle Scholar
- Kottke TE, Battista RN, DeFriese GH, Brekke ML: Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA. 1988, 259 (19): 2883-2889. 10.1001/jama.259.19.2883.View ArticlePubMedGoogle Scholar
- Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001, 345 (11): 790-797. 10.1056/NEJMoa010492.View ArticlePubMedGoogle Scholar
- Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004, 292 (12): 1440-1446. 10.1001/jama.292.12.1440.View ArticlePubMedGoogle Scholar
- Church TS, Earnest CP, Skinner JS, Blair SN: Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA. 2007, 297 (19): 2081-2091. 10.1001/jama.297.19.2081.View ArticlePubMedGoogle Scholar
- Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287 (3): 356-359. 10.1001/jama.287.3.356.View ArticlePubMedGoogle Scholar
- Roberts LJ, Morrow JD: Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radical Biol Med. 2000, 28 (4): 505-513. 10.1016/S0891-5849(99)00264-6.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/13/446/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.